# Talzenna

NDC: 0069-0546
Generic name: talazoparib
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, LIQUID FILLED
Routes: ORAL
Marketing started: 20240417

FDA application: NDA217439

## Active ingredients

- TALAZOPARIB TOSYLATE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0546"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0546
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6fd147f-a77e-4a0b-9280-e82ecc41b4be